Cargando…
Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs
Vascular endothelial growth factor receptor-2 (VEGFR-2) is an attractive target in oncology due to its crucial role in angiogenesis. In this study a DNA vaccine coding for human VEGFR-2 was evaluated in healthy mice and dogs, administered by intradermal injection and electroporation. In mice, three...
Autores principales: | Denies, Sofie, Cicchelero, Laetitia, Polis, Ingeborgh, Sanders, Niek N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905448/ https://www.ncbi.nlm.nih.gov/pubmed/26871296 http://dx.doi.org/10.18632/oncotarget.7265 |
Ejemplares similares
-
Lack of immunogenicity of xenogeneic DNA from porcine biomaterials()()
por: Record Ritchie, Rae D., et al.
Publicado: (2022) -
Immunogenicity Risk Profile of Nanobodies
por: Ackaert, Chloé, et al.
Publicado: (2021) -
Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer: proof-of-principle
por: Steenbrugge, Jonas, et al.
Publicado: (2023) -
CD4(+)CD8(+) T-Lymphocytes in Xenogeneic and Human Graft-versus-Host Disease
por: Alhaj Hussen, Kutaiba, et al.
Publicado: (2020) -
Xenogeneic Graft-Versus-Host Disease in Humanized NSG and NSG-HLA-A2/HHD Mice
por: Ehx, Grégory, et al.
Publicado: (2018)